Dietworks®
US$ 29.49
companies making glp 1 drugs GLP-1 Market Trends and Global Forecasts Report 2025: A $157.5 Bn Market by 2035 GLP-1 Receptor Agonist Market Size
Description
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), initially developed for glycaemic control in patients with type 2 diabetes, have demonstrated significant cardiometabolic benefits
Methods We conducted a population-based propensity-matched retrospective cohort study using TriNetX
New users of GLP-1RAs were matched based on age, demographics, comorbidities and medication use by using 1:1 propensity matching with other glucose-lowering drugs
Learn about eligibility, deadlines, and how to file a claim.
Its no secret that GLP-1 medications help people lose weight
